Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Angiotensin - converting enzyme inhibitor (ACE - inhibitor) used as antihypertensive.
  • Fetal Risk
    Fetal Risk
  • maternal use of angiotensin converting enzyme inhibitors in general during the second and third trimesters is associated with renal and skull defects (hypocalvaria), oligohydramnios and intrauterine death.
  • No human data available about the use of this agent in pregnancy.
  • Breast Feeding
    Breast Feeding
  • Minimal amounts of unchanged Benazepril and of Benazeprilat are excreted into the breast milk of lactating women treated with Benazepril.
  • A newborn child ingesting entirely breast milk would receive less than 0.1% of the mg/kg maternal dose of Benazepril and Benazeprilat.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     6   +   5    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year